Find the latest Nevro Corp. (NVRO) stock quote, history, news and other vital information to help you with your stock trading and investing.

Get the latest Nevro Corp. (NVRO) stock news and headlines to help you in your trading and investing decisions.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

2024年11月8日 · Nevro Corp (NYSE:NVRO) is set to release its Q3 2024 earnings on Nov 11, 2024. The consensus estimate for Q3 2024 revenue is $93.07 million, and the earnings are expected to come in at -$0.76 per ...

2024年8月9日 · In this article, we are going to take a look at where Nevro Corp. (NYSE:NVRO) stands against Engaged Capital's other top holdings.

See the company profile for Nevro Corp. (NVRO) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ...

NVRO expects fourth-quarter 2024 U.S. revenues to be in the range of $91 million-$92 million, representing a decrease of 9% to 10% compared with the fourth quarter of 2023.

2024年9月25日 · Likely Trend of NVRO Stock Following the News Following the announcement, shares of the company closed nearly flat at $5.74 on Tuesday. Nevro continues to cater to a lucrative SCS therapies market.

Truist lowered the firm’s price target on Nevro (NVRO) to $4.70 from $7 and keeps a Hold rating on the shares as part of a broader research note previewing 2025 in Medical Technology.

2024年10月10日 · Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it will release its financial ...